SCIENTIFIC OPINION Scientific Opinion on the substantiation of health claims related to vitamin B6 and protein and glycogen metabolism (ID 65, 70, 71), function of the nervous system (ID 66), red blood cell formation (ID 67, 72, 186), function of the immune system (ID 68), regulation of hormonal activity (ID 69) and mental performance (ID 185) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) European Food Safety Authority (EFSA), Parma, Italy

被引:0
|
作者
Bresson, Jean-Louis [1 ]
Flynn, Albert [1 ]
Heinonen, Marina [1 ]
Hulshof, Karin [1 ]
Korhonen, Hannu [1 ]
Lagiou, Pagona [1 ]
Lovik, Martinus [1 ]
Marchelli, Rosangela [1 ]
Martin, Ambroise [1 ]
Moseley, Bevan [1 ]
Przyrembel, Hildegard [1 ]
Salminen, Seppo [1 ]
Strain, Sean J. J. [1 ]
Strobel, Stephan [1 ]
Tetens, Inge [1 ]
van den Berg, Henk [1 ]
van Loveren, Hendrik [1 ]
Verhagen, Hans [1 ]
机构
[1] EFSA, Parma, Italy
来源
EFSA JOURNAL | 2009年 / 7卷 / 10期
关键词
Vitamin B6; protein; glycogen; metabolism; iron; hormones; immune system; red blood cells; nervous system; health claims;
D O I
暂无
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies was asked to provide a scientific opinion on a list of health claims pursuant to Article 13 of Regulation (EC) No 1924/2006. This opinion addresses the scientific substantiation of health claims in relation to vitamin B6 and the following claimed effects: protein and glycogen metabolism, function of the nervous system, red blood cell formation, function of the immune system, regulation of hormonal activity and mental performance. The scientific substantiation is based on the information provided by the Member States in the consolidated list of Article 13 health claims and references that EFSA has received from Member States or directly from stakeholders. The food constituent that is the subject of the health claims is vitamin B6, which is a well recognised nutrient and is measurable in foods by established methods. The Panel considers that vitamin B6 is sufficiently characterised. The Panel concludes that a cause and effect relationship has been established between the dietary intake of vitamin B6 and normal protein and glycogen metabolism, normal function of the nervous system, normal red blood cell formation, normal function of the immune system and regulation of hormonal activity. The evidence provided does not establish that inadequate intake of vitamin B6 leading to impaired function of the above health relationships occurs in the general EU population. The Panel considers that, in order to bear the claims, a food should be at least a source of vitamin B6 as per Annex to Regulation (EC) No 1924/2006. Such amounts can be easily consumed as part of a balanced diet. The target population is the general population. The Panel considers that the claim for vitamin B6 and mental performance encourages excess consumption of vitamin B6 and therefore does not comply with the criteria laid down in Regulation (EC) No 1924/2006.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Scientific Opinion on the substantiation of health claims related to zeaxanthin and maintenance of normal vision (ID 1684, 2169, 2888) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Harmu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2010, 8 (10)
  • [32] Scientific Opinion on the substantiation of health claims related to shark cartilage and maintenance of joints (ID 1852, 1853) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)(2)
    Bresson, Jean-Louis
    Flynn, Albert
    Heinonen, Marina
    Hulshof, Karin
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Przyrembel, Hildegard
    Salminen, Seppo
    Strain, Sean J. J.
    Strobel, Stephan
    Tetens, Inge
    Van den Berg, Henk
    Van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2009, 7 (10)
  • [33] Scientific Opinion on the substantiation of health claims related to linoleic acid and maintenance of normal blood cholesterol concentrations (ID 489) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Bresson, Jean-Louis
    Flynn, Albert
    Heinonen, Marina
    Hulshof, Karin
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Przyrembel, Hildegard
    Salminen, Seppo
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    van den Berg, Henk
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2009, 7 (10)
  • [34] Scientific Opinion on the substantiation of health claims related to Fagopyrum esculentum Moench. and function of the upper respiratory tract (ID 2442) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Bresson, Jean-Louis
    Flynn, Albert
    Heinonen, Marina
    Hulshof, Karin
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Przyrembel, Hildegard
    Salminen, Seppo
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    van den Berg, Henk
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2009, 7 (10)
  • [35] Scientific Opinion on the substantiation of health claims related to Ocimum basilicum L. and improvement of diuretic function (ID 2314, 3465) pursuant to Article 13( 1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Bresson, Jean-Louis
    Flynn, Albert
    Heinonen, Marina
    Hulshof, Karin
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Przyrembel, Hildegard
    Salminen, Seppo
    Strain, Sean
    van den Berg, Henk
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2009, 7 (10)
  • [36] Scientific Opinion on the substantiation of health claims related to Lathyrus pratensis L. and function of the upper respiratory tract (ID 2456) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Bresson, Jean-Louis
    Flynn, Albert
    Heinonen, Marina
    Hulshof, Karin
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Przyrembel, Hildegard
    Salminen, Seppo
    Strain, Sean
    van den Berg, Henk
    van Loveren, Hendrik
    EFSA JOURNAL, 2009, 7 (10)
  • [37] Scientific Opinion on the substantiation of health claims related to Justicia gendarussa L. and improvement of diuretic function (ID 2455) and reduction of inflammation of the lower urinary tract (ID 2455) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Bresson, Jean-Louis
    Flynn, Albert
    Heinonen, Marina
    Hulshof, Karin
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Przyrembel, Hildegard
    Salminen, Seppo
    Strain, Sean
    van den Berg, Henk
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2009, 7 (10)
  • [38] Scientific Opinion on the substantiation of health claims related to Lactobacillus plantarum 299 (DSM 6595, 67B) and immune system (ID 1077) pursuant to Article 13(1) of Regulation (EC) No 1924/20061 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Bresson, Jean-Louis
    Flynn, Albert
    Heinonen, Marina
    Hulshof, Karin
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Przyrembel, Hildegard
    Salminen, Seppo
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    van den Berg, Henk
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2009, 7 (10)
  • [39] Scientific opinion on the substantiation of health claims related to Equisetum arvense L. and invigoration of the body (ID 2437), maintenance of skin (ID 2438), maintenance of hair (ID 2438), maintenance of bone (ID 2439), and maintenance or achievement of a normal body weight (ID 2783) pursuant to Article 13 of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Bresson, Jean-Louis
    Flynn, Albert
    Heinonen, Marina
    Hulshof, Karin
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Przyrembel, Hildegard
    Salminen, Seppo
    Strain, Sean J. J.
    Strobel, Stephan
    Tetens, Inge
    Van den Berg, Henk
    Van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2009, 7 (10)
  • [40] Scientific Opinion on the substantiation of health claims related to resistant starch and reduction of post-prandial glycaemic responses (ID 681), "digestive health benefits" (ID 682) and "favours a normal colon metabolism" (ID 783) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    Agostoni, Carlo
    Bresson, Jean-Louis
    Fairweather-Tait, Susan
    Flynn, Albert
    Golly, Ines
    Korhonen, Hannu
    Lagiou, Pagona
    Lovik, Martinus
    Marchelli, Rosangela
    Martin, Ambroise
    Moseley, Bevan
    Neuhaeuser-Berthold, Monika
    Przyrembel, Hildegard
    Salminen, Seppo
    Sanz, Yolanda
    Strain, Sean
    Strobel, Stephan
    Tetens, Inge
    Tome, Daniel
    van Loveren, Hendrik
    Verhagen, Hans
    EFSA JOURNAL, 2011, 9 (04)